[{"NetIncomeLoss_2_Q2_USD":-263087000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":53328000.0,"TreasuryStockCommonShares_0_Q2_shares":3033.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":1709000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":2367000.0,"PaymentsForRestructuring_1_Q2_USD":14558000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":383652000.0,"Depreciation_1_Q2_USD":700000.0,"Depreciation_2_Q2_USD":1331000.0,"RestructuringReserveSettledWithoutCash2_1_Q2_USD":2438000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":7416000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":51926074.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":2686000.0,"AssetsCurrent_0_Q2_USD":785384000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":211771000.0,"RestructuringCharges_2_Q2_USD":28402000.0,"RestructuringCharges_1_Q2_USD":28402000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":108355000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":38224000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7735433.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":7735433.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":387000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":2501000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":595769000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":98000.0,"CommonStockSharesIssued_0_Q2_shares":51938012.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":51917417.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ResearchAndDevelopmentExpense_2_Q2_USD":136930000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":73320000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":51917417.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":51926074.0,"AssetsFairValueDisclosure_0_Q2_USD":756522000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":89000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-66000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":-304000.0,"CommonStockValue_0_Q2_USD":5000.0,"Revenues_2_Q2_USD":3375000.0,"Revenues_1_Q2_USD":1089000.0,"MarketableSecuritiesCurrent_0_Q2_USD":498294000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":3546000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-133846000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-12815000.0,"OtherAssetsNoncurrent_0_Q2_USD":3415000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":258228000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":22661000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":2645255000.0,"Liabilities_0_Q2_USD":87327000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":3546000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":414000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":2501000.0,"TreasuryStockCommonValue_0_Q2_USD":400000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-262673000.0,"Assets_0_Q2_USD":827242000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":414000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":2501000.0,"StockholdersEquity_0_Q2_USD":739915000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":346000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":496585000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":12668833.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1906654000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":131523000.0,"AssetImpairmentCharges_2_Q2_USD":0.0,"CommonStockSharesOutstanding_0_Q2_shares":51934979.0,"InvestmentsFairValueDisclosure_0_Q2_USD":498294000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":5830000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":1807000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":374000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":24168000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":51917417.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":51926074.0,"LiabilitiesCurrent_0_Q2_USD":64292000.0,"AccountsPayableCurrent_0_Q2_USD":2387000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":28862000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":258228000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1062000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":260595000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":8077000.0,"NetIncomeLoss_1_Q2_USD":-136347000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-255675000.0,"ProfitLoss_2_Q2_USD":-263087000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-5.07,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-2.63,"IncrementalCommonSharesAttributableToConversionOfPreferredStock_2_Q2_shares":0.0,"IncrementalCommonSharesAttributableToConversionOfPreferredStock_1_Q2_shares":0.0,"ShareBasedCompensation_2_Q2_USD":55142000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":27999000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":37.16,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2162000.0,"CommonStockSharesAuthorized_0_Q2_shares":120000000.0,"OperatingIncomeLoss_2_Q2_USD":-270592000.0,"OperatingIncomeLoss_1_Q2_USD":-138967000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":4077818.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":498294000.0,"RestructuringReserve_0_Q2_USD":11406000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":827242000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":7564000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":55142000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":24032000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":13907000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":8577000.0,"OperatingExpenses_2_Q2_USD":273967000.0,"OperatingExpenses_1_Q2_USD":140056000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-34082000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-378000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":5599000.0,"Ticker":"SAGE","CIK":"1597553","name":"SAGE THERAPEUTICS, INC.","OfficialName":"Sage Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"2034401653.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]